• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于检测猫血清和尿液中胱抑素C的人源颗粒增强比浊法的分析验证

Analytical validation of a human particle-enhanced nephelometric assay for cystatin C measurement in feline serum and urine.

作者信息

Ghys Liesbeth F E, Meyer Evelyne, Paepe Dominique, Delanghe Joris, Daminet Sylvie

机构信息

Department of Medicine and Clinical Biology of Small Animals, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium.

出版信息

Vet Clin Pathol. 2014 Jun;43(2):226-34. doi: 10.1111/vcp.12144. Epub 2014 Apr 28.

DOI:10.1111/vcp.12144
PMID:24773065
Abstract

BACKGROUND

In people and dogs, Cystatin C (CysC), a renal glomerular and tubular marker, seems superior to serum creatinine to estimate the glomerular filtration rate (GFR). A particle-enhanced nephelometric immunoassay is available to measure human CysC, but there are no reports in cats.

OBJECTIVE

The goal of this study was the validation of the human CysC nephelometric assay with feline serum and urine, and to perform a pilot study comparing serum and urine CysC between healthy cats and cats with chronic kidney disease (CKD).

METHODS

Western blot analysis was used to assess cross-reactivity between the polyclonal rabbit anti-human CysC antibody and feline CysC. Imprecision and linearity were determined for feline serum and urine CysC. Serum and urine CysC were measured in 10 healthy and 10 CKD cats.

RESULTS

Cross-reactivity between the polyclonal rabbit anti-human CysC antibody and feline CysC was demonstrated. Intra- and inter-assay coefficients of variation in feline serum and urine were 1.3% and 0.4%, and 12.5%, and 4.1%, respectively. Cats with CKD had a significantly higher serum CysC concentration (1.24 [0.63-2.99] vs 0.79 [0.43-1.05] mg/L; P = .02) and urine CysC/urinary Creatinine (uCr) ratio (565.6 [0-1311] vs < 0.049/uCr mg/mol; P = .005) compared with healthy cats.

CONCLUSIONS

The human nephelometric assay showed satisfactory validation results for feline CysC. Cats with CKD had a significantly higher sCysC concentration and uCysC/uCr ratio compared with healthy cats. Additional studies are necessary to evaluate CysC as an early marker of renal damage in cats.

摘要

背景

在人和犬中,作为肾小球和肾小管标志物的胱抑素C(CysC)在估算肾小球滤过率(GFR)方面似乎优于血清肌酐。有一种颗粒增强散射比浊免疫分析法可用于检测人CysC,但在猫中尚无相关报道。

目的

本研究的目的是验证人CysC散射比浊法在猫血清和尿液中的应用,并进行一项初步研究,比较健康猫和慢性肾病(CKD)猫的血清和尿液CysC。

方法

采用蛋白质印迹分析评估兔抗人CysC多克隆抗体与猫CysC之间的交叉反应性。测定猫血清和尿液CysC的不精密度和线性。对10只健康猫和10只CKD猫进行血清和尿液CysC检测。

结果

证实兔抗人CysC多克隆抗体与猫CysC之间存在交叉反应性。猫血清和尿液的批内和批间变异系数分别为1.3%和0.4%,以及12.5%和4.1%。与健康猫相比,CKD猫的血清CysC浓度显著更高(1.24 [0.63 - 2.99] 对 0.79 [0.43 - 1.05] mg/L;P = .02),尿液CysC/尿肌酐(uCr)比值也显著更高(565.6 [0 - 1311] 对 < 0.049/uCr mg/mol;P = .005)。

结论

人散射比浊法对猫CysC的验证结果令人满意。与健康猫相比,CKD猫的血清CysC浓度和尿液CysC/uCr比值显著更高。需要进一步研究以评估CysC作为猫肾损伤早期标志物的价值。

相似文献

1
Analytical validation of a human particle-enhanced nephelometric assay for cystatin C measurement in feline serum and urine.用于检测猫血清和尿液中胱抑素C的人源颗粒增强比浊法的分析验证
Vet Clin Pathol. 2014 Jun;43(2):226-34. doi: 10.1111/vcp.12144. Epub 2014 Apr 28.
2
Evaluation of Cystatin C for the Detection of Chronic Kidney Disease in Cats.胱抑素C用于检测猫慢性肾病的评估
J Vet Intern Med. 2016 Jul;30(4):1074-82. doi: 10.1111/jvim.14256.
3
Serum and urinary cystatin C in cats with feline immunodeficiency virus infection and cats with hyperthyroidism.感染猫免疫缺陷病毒的猫和甲状腺功能亢进的猫的血清及尿胱抑素C
J Feline Med Surg. 2016 Aug;18(8):658-65. doi: 10.1177/1098612X15592343. Epub 2015 Jun 22.
4
Routine kidney variables, glomerular filtration rate and urinary cystatin C in cats with diabetes mellitus, cats with chronic kidney disease and healthy cats.患有糖尿病的猫、患有慢性肾病的猫和健康猫的常规肾脏指标、肾小球滤过率及尿胱抑素C
J Feline Med Surg. 2015 Oct;17(10):880-8. doi: 10.1177/1098612X14559788. Epub 2014 Nov 25.
5
Biological validation of feline serum cystatin C: The effect of breed, age and sex and establishment of a reference interval.猫血清胱抑素C的生物学验证:品种、年龄和性别的影响及参考区间的建立
Vet J. 2015 May;204(2):168-73. doi: 10.1016/j.tvjl.2015.02.018. Epub 2015 Feb 26.
6
Serum Cystatin C Concentrations in Cats with Hyperthyroidism and Chronic Kidney Disease.患有甲状腺功能亢进和慢性肾病的猫的血清胱抑素C浓度
J Vet Intern Med. 2016 Jul;30(4):1083-9. doi: 10.1111/jvim.13956. Epub 2016 May 7.
7
Cystatin C: a new renal marker and its potential use in small animal medicine.胱抑素C:一种新的肾脏标志物及其在小动物医学中的潜在应用。
J Vet Intern Med. 2014 Jul-Aug;28(4):1152-64. doi: 10.1111/jvim.12366. Epub 2014 May 9.
8
Evaluation of urinary biomarkers for azotaemic chronic kidney disease in cats.猫氮血症性慢性肾病尿液生物标志物的评估
J Small Anim Pract. 2016 Mar;57(3):122-9. doi: 10.1111/jsap.12439. Epub 2015 Dec 24.
9
Measurement of cystatin C in human urine by particle-enhanced turbidimetric immunoassay on an automated biochemistry analyzer.应用全自动生化分析仪的胶乳增强散射比浊法测定人尿液中的胱抑素 C。
Clin Biochem. 2013 Aug;46(12):1128-1130. doi: 10.1016/j.clinbiochem.2013.05.072. Epub 2013 Jun 12.
10
Cystatin C analysis in the dog: a comparison of turbidimetric and nephelometric assay results.犬胱抑素C分析:比浊法与散射比浊法检测结果的比较
Acta Vet Hung. 2010 Mar;58(1):59-67. doi: 10.1556/AVet.58.2010.1.6.

引用本文的文献

1
Comparison of Three Different Diagnostic Assays for Fibroblast Growth Factor-23 (FGF-23) Measurements in Cats: A Pilot Study.三种不同诊断方法检测猫成纤维细胞生长因子-23(FGF-23)的比较:一项初步研究
Animals (Basel). 2023 Jun 2;13(11):1853. doi: 10.3390/ani13111853.
2
Renal biomarkers in cats: A review of the current status in chronic kidney disease.猫的肾脏生物标志物:慢性肾脏病现状综述。
J Vet Intern Med. 2022 Mar;36(2):379-396. doi: 10.1111/jvim.16377. Epub 2022 Feb 26.
3
Updates on Laboratory Evaluation of Feline Cardiac Diseases.
猫心脏疾病实验室评估的最新进展。
Vet Sci. 2021 Mar 3;8(3):41. doi: 10.3390/vetsci8030041.
4
A Review of Specific Biomarkers of Chronic Renal Injury and Their Potential Application in Nonclinical Safety Assessment Studies.慢性肾损伤特异性生物标志物的研究进展及其在非临床安全性评价研究中的潜在应用。
Toxicol Pathol. 2021 Jul;49(5):996-1023. doi: 10.1177/0192623320985045. Epub 2021 Feb 12.
5
Evaluation of Cystatin C for the Detection of Chronic Kidney Disease in Cats.胱抑素C用于检测猫慢性肾病的评估
J Vet Intern Med. 2016 Jul;30(4):1074-82. doi: 10.1111/jvim.14256.
6
Serum Cystatin C Concentrations in Cats with Hyperthyroidism and Chronic Kidney Disease.患有甲状腺功能亢进和慢性肾病的猫的血清胱抑素C浓度
J Vet Intern Med. 2016 Jul;30(4):1083-9. doi: 10.1111/jvim.13956. Epub 2016 May 7.
7
Serum and urinary cystatin C in cats with feline immunodeficiency virus infection and cats with hyperthyroidism.感染猫免疫缺陷病毒的猫和甲状腺功能亢进的猫的血清及尿胱抑素C
J Feline Med Surg. 2016 Aug;18(8):658-65. doi: 10.1177/1098612X15592343. Epub 2015 Jun 22.
8
Urinary albumin and transferrin as early diagnostic markers of chronic kidney disease.尿白蛋白和转铁蛋白作为慢性肾脏病的早期诊断标志物。
J Vet Med Sci. 2015 Aug;77(8):937-43. doi: 10.1292/jvms.14-0427. Epub 2015 Mar 28.
9
Routine kidney variables, glomerular filtration rate and urinary cystatin C in cats with diabetes mellitus, cats with chronic kidney disease and healthy cats.患有糖尿病的猫、患有慢性肾病的猫和健康猫的常规肾脏指标、肾小球滤过率及尿胱抑素C
J Feline Med Surg. 2015 Oct;17(10):880-8. doi: 10.1177/1098612X14559788. Epub 2014 Nov 25.
10
Cystatin C: a new renal marker and its potential use in small animal medicine.胱抑素C:一种新的肾脏标志物及其在小动物医学中的潜在应用。
J Vet Intern Med. 2014 Jul-Aug;28(4):1152-64. doi: 10.1111/jvim.12366. Epub 2014 May 9.